Both in Pharmaceuticals

Valion Bio vs Matinas BioPharma Holdings

Over the past year VBIO returned −75.7% and MTNB returned −45.6%; their daily moves had a correlation of -0.01.

VBIO −75.7% MTNB −45.6%Growth of $1, one year, split-adjusted
MetricVBIOMTNB
Price$0.5500$1.51
Market cap$1.2M$1.5M
Today−10.83%−20.53%
1 month−78.1%−37.6%
6 months—−85.6%
Year to date—−82.8%
1 year—−92.5%
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales——
Net cash-$5.3M$755.0K
Dividend yield——
Volatility (60d)—775.0%
Short % of float9.4%0.5%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).